Screener
Oruka Therapeutics, Inc. ORKA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
FAQ
- What is Oruka Therapeutics, Inc.'s enterprise value?
- Oruka Therapeutics, Inc. (ORKA) reported enterprise value of $2.38B in Q1 2026.
- How has Oruka Therapeutics, Inc.'s enterprise value changed year-over-year?
- Oruka Therapeutics, Inc.'s enterprise value increased by 690.1% year-over-year, from $301.51M to $2.38B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Oruka Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude